>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
姜黄素治疗代谢综合征临床研究进展
作者:秦思  胡怀东 
单位:重庆医科大学附属第二医院 营养科, 重庆 400010
关键词:姜黄素 代谢综合征 临床研究进展 
分类号:R589
出版年·卷·期(页码):2018·37·第一期(165-168)
摘要:

姜黄素是一种存在于传统香料姜黄根部的多酚类物质,其通过多种机制在代谢综合征中发挥抗氧化和抗炎活性。在临床运用中,姜黄素具有减少炎症因子、改善糖代谢紊乱、调节肥胖人群的心理状态以及延缓非酒精性脂肪性肝病进展等多种作用,但其对脂质代谢的影响具有争议,仍需进一步探讨。姜黄素的上述作用使其在临床治疗代谢综合征中发挥重要作用。

参考文献:

[1] KUNNUMAKKARA A B,BORDOLOI D,PADMAVATHI G,et al.Curcumin,the golden nutraceutical:multitargeting for multiple chronic diseases[J].Br J Pharmacol,2017,174(11):1325-1348.
[2] SAHEBKAR A.Why it is necessary to translate curcumin into clinical practice for the prevention and treatment of metabolic syndrome?[J] Biofactors,2013,39(2):197-208.
[3] AMIN F,ISLAM N,ANILA N,et al.Clinical efficacy of the co-administration of turmeric and black seeds (kalongi) in metabolic syndrome-a double blind randomized controlled trial-tak-mets trial[J].Complement Ther Med,2015,23(2):165-174.
[4] CHUENGSAMARN S,RATTANAMONGKOLGUL S,LUECHAPUDIPORN R,et al.Curcumin extract for prevention of type 2 diabetes[J].Diabetes Care,2012,35(11):2121-2127.
[5] CHUENGSAMARN S,RATTANAMONGKOLGUL S,PHONRAT B,et al.Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract:a randomized controlled trial[J].J Nutr Biochem,2014,25(2):144-150.
[6] KHAJEHDEHI P,PAKFETRAT M,JAVIDNIA K,et al.Oral supplementation of turmeric attenuates proteinuria,transforming growth factor-beta and interleukin-8 levels in patients with overt type 2 diabetic nephropathy:a randomized,double-blind and placebo-controlled study[J].Scand J Urol Nephrol,2011,45(5):365-370.
[7] MAITHILI K S N,SRIDHAR M G,SWAMINATHAN R P,et al.Efficacy of turmeric as adjuvant therapy in type 2 diabetic patients[J].Indian J Clin Biochem,2015,30(2):180-186.
[8] MOHAMMADI A,SAHEBKAR A,IRANSHAHI M,et al.Effects of supplementation with curcuminoids on dyslipidemia in obese patients:a randomized crossover trial[J].Phytother Res,2013,27(3):374-379.
[9] PANAHI Y,HOSSEINI M S,KHALILI N,et al.Antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome:a randomized controlled trial and an updated meta-analysis[J].Clin Nutr,2015,34(6):1101-1108.
[10] PANAHI Y,HOSSEINI M S,KHALILI N,et al.Effects of curcumin on serum cytokine concentrations in subjects with metabolic syndrome:a post-hoc analysis of a randomized controlled trial[J].Biomed Pharmacother,2016,82:578-582.
[11] PANAHI Y,KHALILI N,HOSSEINI M S,et al.Lipid-modifying effects of adjunctive therapy with curcuminoids-piperine combination in patients with metabolic syndrome:results of a randomized controlled trial[J].Complement Ther Med,2014,22(5):851-857.
[12] PANAHI Y,KIANPOUR P,MOHTASHAMI R,et al.Curcumin lowers serum lipids and uric acid in subjects with nonalcoholic fatty liver disease:a randomized controlled trial[J].J Cardiovasc Pharmacol,2016,68(3):223-229.
[13] RAHIMI H R,MOHAMMADPOUR A H,DASTANI M,et al. The effect of nano-curcumin on HbA1c,fasting blood glucose,and lipid profile in diabetic subjects:a randomized clinical trial[J].Avicenna J Phytomed,2016,6(5):567-577.
[14] RAHMANI S,ASGARY S,ASKARI G,et al.Treatment of non-alcoholic fatty liver disease with curcumin:a randomized placebo-controlled trial[J].Phytother Res,2016,30(9):1540-1548.
[15] YANG Y S,SU Y F,YANG H W,et al.Lipid-lowering effects of curcumin in patients with metabolic syndrome:a randomized,double-blind,placebo-controlled trial[J].Phytother Res,2014,28(12):1770-1777.
[16] SAHEBKAR A.Curcuminoids for the management of hypertriglyceridaemia[J].Nat Rev Cardiol,2014,11(2):123.
[17] SAHEBKAR A.A systematic review and meta-analysis of randomized controlled trials investigating the effects of curcumin on blood lipid levels[J].Clin Nutr,2014,33(3):406-414.
[18] ESMAILY H,SAHEBKAR A,IRANSHAHI M,et al.An investigation of the effects of curcumin on anxiety and depression in obese individuals:a randomized controlled trial[J].Chin J Integr Med,2015,21(5):332-338.
[19] LASTRA G,MANRIQUE C.Perivascular adipose tissue,inflammation and insulin resistance:link to vascular dysfunction and cardiovascular disease[J].Horm Mol Biol Clin Investig,2015,22(1):19-26.
[20] 许崇德,成之福.姜黄素改善2型糖尿病的机制研究进[J].医药导报,2016,35(11):1234-1237.
[21] SUN Y,PENG M L.Recent advances in curcumin and its derivatives for treatment of liver diseases[J].Yao Xue Xue Bao,2014,49(11):1483-1490.
[22] GULSEREN I,GURI A,CORREDIG M.Effect of interfacial composition on uptake of curcumin-piperine mixtures in oil in water emulsions by caco-2 cells[J].Food Funct,2014,5(6):1218-1223.
[23] HU L,SHI Y,LI J H,et al.Enhancement of oral bioavailability of curcumin by a novel solid dispersion system[J].AAPS PharmSciTech,2015,16(6):1327-1334.
[24] ADITYA N P,YANG H,KIM S,et al.Fabrication of amorphous curcumin nanosuspensions using beta-lactoglobulin to enhance solubility,stability,and bioavailability[J].Colloids Surf B Biointerfaces,2015,127:114-121.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 405717 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-83272481 83272483
电子邮件:
bjb@pub.seu.edu.cn

苏ICP备09058364